home
about us
member log-in
contact us

PRODUCTS
MUNICIPAL BONDS
INDEX FUNDS
- Total Asset Fund (TAF)
EVENTS
MARKET RESEARCH

Recent Quotes

View Full List

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

Trevi Therapeutics, Inc. - Common Stock (NQ:TRVI)

10.98 -0.38 (-3.35%)

Streaming Delayed Price Updated: 4:00 PM EST, Jan 6, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Trevi Therapeutics, Inc. - Common Stock

< Previous 1 2 3 4 5 Next >

Why Trevi Therapeutics Could Be a Triple-Bagger Biotech Stock

September 06, 2024

Wall Street analysts see big potential upside for small-cap biopharma firm Trevi Therapeutics. So, what does the firm do and how does it stand out?

Via MarketBeat

TRVI Stock Earnings: Trevi Therapeutics Misses EPS for Q2 2024 ↗

August 08, 2024

TRVI stock results show that Trevi Therapeutics missed analyst estimates for earnings per share the second quarter of 2024.

Via InvestorPlace

12 Health Care Stocks Moving In Thursday's After-Market Session ↗

June 06, 2024

Via Benzinga

TRVI Stock Earnings: Trevi Therapeutics Misses EPS for Q1 2024 ↗

May 07, 2024

TRVI stock results show that Trevi Therapeutics missed analyst estimates for earnings per share the first quarter of 2024.

Via InvestorPlace

TRVI Stock Earnings: Trevi Therapeutics Beats EPS for Q4 2023 ↗

March 20, 2024

TRVI stock results show that Trevi Therapeutics beat analyst estimates for earnings per share the fourth quarter of 2023.

Via InvestorPlace

Trevi Therapeutics: Q4 Earnings Insights ↗

March 20, 2024

Via Benzinga

Earnings Outlook For Trevi Therapeutics ↗

March 19, 2024

Via Benzinga

Trevi Therapeutics's Earnings: A Preview ↗

November 08, 2023

Via Benzinga

Recap: Trevi Therapeutics Q1 Earnings ↗

May 11, 2023

Via Benzinga

Earnings Scheduled For March 20, 2024 ↗

March 20, 2024

Companies Reporting Before The Bell • UP Fintech Holding (NASDAQ:TIGR) is expected to report quarterly earnings at $0.07 per share on revenue of $207.00 million.

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗

August 01, 2023

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Intraday Session ↗

April 18, 2023

Via Benzinga

Earnings Outlook For Trevi Therapeutics ↗

March 15, 2023

Via Benzinga

Trevi Therapeutics Shares Jump After Complete Data From Chronic Cough Trial ↗

September 19, 2022

Via Benzinga

Earnings Scheduled For November 9, 2023 ↗

November 09, 2023

Companies Reporting Before The Bell • Indivior (NASDAQ:INDV) is expected to report quarterly earnings at $0.30 per share on revenue of $265.00 million.

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗

April 18, 2023

Via Benzinga

Earnings Scheduled For August 10, 2023 ↗

August 10, 2023

Companies Reporting Before The Bell • IDEX Biometrics (NASDAQ:IDBA) is estimated to report quarterly loss at $0.39 per share on revenue of $1.60 million.

Via Benzinga

Earnings Preview: Trevi Therapeutics ↗

May 10, 2023

Via Benzinga

Earnings Scheduled For May 11, 2023 ↗

May 11, 2023

Companies Reporting Before The Bell • Takeda Pharmaceutical (NYSE:TAK) is likely to report earnings for its fourth quarter. • Exela Technologies (NASDAQ:XELA) is expected to report earnings for its...

Via Benzinga

Earnings Scheduled For March 16, 2023 ↗

March 16, 2023

Companies Reporting Before The Bell • KVH Industries (NASDAQ:KVHI) is projected to report quarterly earnings at $0.03 per share on revenue of $34.29 million.

Via Benzinga

Why Glory Star New Media Group Shares Are Trading Higher By 122%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session ↗

April 18, 2023

Gainers Glory Star New Media Group Holdings Limited (NASDAQ: GSMG) shares jumped 122% to $1.07 after the company announced the signing of a $60 million strategic investment with two institutional...

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For March 14, 2023 ↗

March 14, 2023

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For April 12, 2023 ↗

April 12, 2023

Via Benzinga

Trevi Therapeutics, Inc. Discusses Progress and 2022 Success of Clinical Studies for Its Investigational Oral Therapy Haduvio(TM) with The Stock Day Podcast

January 25, 2023

Phoenix, Arizona--(Newsfile Corp. - January 25, 2023) - The Stock Day Podcast welcomed Trevi Therapeutics, Inc. (NASDAQ: TRVI) ("the Company"),...

Via Newsfile

Why Manchester United Shares Are Trading Higher By Around 10%; Here Are 20 Stocks Moving Premarket ↗

November 23, 2022

Gainers COMSovereign Holding Corp. (NASDAQ: COMS) shares rose 58.4% to $0.1069 in pre-market trading after gaining more than 16% on Tuesday.

Via Benzinga

Earnings Scheduled For November 10, 2022 ↗

November 10, 2022

Companies Reporting Before The Bell • IDEX Biometrics (NASDAQ:IDBA) is estimated to report earnings for its third quarter.

Via Benzinga

Earnings Outlook For Trevi Therapeutics, Inc. - Common Stock ↗

November 09, 2022

Trevi Therapeutics, Inc. - Common Stock (NASDAQ:TRVI) is set to give its latest quarterly earnings report on Thursday, 2022-11-10. Here's what investors need to know before the announcement.

Via Benzinga

Why SOBR Safe Shares Surged Around 233%; Here Are 68 Biggest Movers From Yesterday ↗

September 21, 2022

Gainers

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Intraday Session ↗

September 20, 2022

Via Benzinga

Trevi Therapeutics, Inc. Discusses Commercialization for Its Investigational Therapy, Haduvio, with The Stock Day Podcast

August 22, 2022

Phoenix, Arizona--(Newsfile Corp. - August 22, 2022) - The Stock Day Podcast welcomed Trevi Therapeutics, Inc. (NASDAQ: TRVI) ("the Company"),...

Via Newsfile

< Previous 1 2 3 4 5 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Home
About Us
Products
Municipal Bonds
Index Funds
Seminars & Events
Market Research
Contact Us
Member Section
Privacy Policy
Terms & Conditions
Security Notice
Customer Service

Securities offered through Purshe Kaplan Sterling Investments, member FINRA / SIPC, Headquartered at 80 State Street,
Albany, NY 12207
Purshe Kaplan Sterling Investments and Tamar Securities, LLC are not affiliated companies.
Tamar Securities, LLC is a Registered Investment Adviser. Advisory services are only offered to clients or prospective clients where Tamar Securities, LLC
and its representatives are properly licensed or exempt from licensure. Past performance is no guarantee of future returns. Investing involves risk and possible loss of principal capital.
No advice may be rendered by Tamar Securities, LLC unless a client service agreement is in place.

NOT FDIC INSURED. NOT BANK GUARANTEED. MAY LOSE VALUE, INCLUDING LOSS OF PRINCIPAL. NOT INSURED BY ANY STATE OR FEDERAL AGENCY.
Web development by IBCnet.com